{"organizations": [], "uuid": "64eef41790380c9c5c04d9760e1a3480c1c2848c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-alexion-to-acquire-wilson-therapeu/brief-alexion-to-acquire-wilson-therapeutics-idUSASC09VHW", "country": "US", "domain_rank": 408, "title": "BRIEF-Alexion To Acquire Wilson Therapeutics", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-11T09:03:00.000+03:00", "replies_count": 0, "uuid": "64eef41790380c9c5c04d9760e1a3480c1c2848c"}, "author": "", "url": "https://www.reuters.com/article/brief-alexion-to-acquire-wilson-therapeu/brief-alexion-to-acquire-wilson-therapeutics-idUSASC09VHW", "ord_in_thread": 0, "title": "BRIEF-Alexion To Acquire Wilson Therapeutics", "locations": [], "entities": {"persons": [{"name": "wilson", "sentiment": "none"}], "locations": [], "organizations": [{"name": "acquire wilson therapeutics", "sentiment": "negative"}, {"name": "brief-alexion to acquire wilson therapeutics reute", "sentiment": "negative"}, {"name": "alexion", "sentiment": "none"}, {"name": "alexion pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 11, 2018 / 6:07 AM / Updated 27 minutes ago BRIEF-Alexion To Acquire Wilson Therapeutics Reuters Staff \nApril 11 (Reuters) - Alexion Pharmaceuticals Inc: * ALEXION TO ACQUIRE WILSON THERAPEUTICS \n* SAYS ALEXION WILL ACQUIRE WILSON THERAPEUTICS THROUGH A TENDER OFFER \n* SAYS TOTAL EQUITY VALUE OF TRANSACTION AMOUNTS TO SEK 7,100 MILLION, OR APPROXIMATELY $855 MILLION \n* SAYS ALEXION INTENDS TO FINANCE ACQUISITION THROUGH CASH ON HAND. Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-11T09:03:00.000+03:00", "crawled": "2018-04-11T09:23:11.016+03:00", "highlightTitle": ""}